Marker Therapeutics, Inc. (MRKR) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 41 transactions totaling $106.6M, demonstrating a bullish sentiment with $106.6M in net insider flow. The most recent transaction on Mar 24, 2022 involved a transaction of 36,076 shares valued at $17.3K.
No significant insider buying has been recorded for MRKR in the recent period.
No significant insider selling has been recorded for MRKR in the recent period.
Based on recent SEC filings, insider sentiment for MRKR is bullish with an Insider Alignment Score of 100/100 and a net flow of $106.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Marker Therapeutics, Inc. (MRKR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading MRKR stock, having executed 41 transactions in the past 90 days. The most active insider is Partners 16, L.p. Nea (Executive), who has made 1 transactions totaling $10.0M.
Get notified when executives and directors at MRKR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 24, 2022 | H. Kim Anthony | Executive | Payment | 36,076 | $0.48 | $17.3K | |
| Mar 24, 2022 | H. Kim Anthony | Executive | Award | 150,512 | $N/A | $0 | |
| Mar 24, 2022 | Vera Juan | Executive | Payment | 33,465 | $0.48 | $16.1K | |
| Mar 24, 2022 | Vera Juan | Executive | Award | 140,823 | $N/A | $0 | |
| Mar 24, 2022 | L. Hoang Peter | Executive | Payment | 48,376 | $0.48 | $23.2K | |
| Mar 24, 2022 | L. Hoang Peter | Executive | Award | 199,094 | $N/A | $0 | |
| Jun 8, 2021 | Robert Wilson John | Executive | Award | 12,658 | $N/A | $0 | |
| Jun 8, 2021 | David Eansor Norman | Executive | Award | 12,658 | $N/A | $0 | |
| Jun 8, 2021 | Elms Steve | Executive | Award | 12,658 | $N/A | $0 | |
| Jun 8, 2021 | Laskow-pooley David | Executive | Award | 12,658 | $N/A | $0 | |
| Jun 8, 2021 | Gerald Wasserman Frederick | Executive | Award | 12,658 | $N/A | $0 | |
| May 18, 2021 | Gerald Wasserman Frederick | Executive | Purchase | 10,000 | $2.41 | $24.1K | |
| Mar 25, 2021 | David Eansor Norman | Executive | Gift | 7,142 | $N/A | $0 | |
| Mar 25, 2021 | David Eansor Norman | Executive | Gift | 14,285 | $N/A | $0 | |
| Mar 25, 2021 | David Eansor Norman | Executive | Gift | 7,142 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $106.6M | 99.5% |
Exercise (Options)(X) | 1 | $500.0K | 0.5% |
Payment(F) | 3 | $56.6K | 0.1% |
Award(A) | 17 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insiders at Marker Therapeutics, Inc. are accumulating shares at an accelerated pace. With 19 insiders making 41 transactions totaling $106.6M in purchases versus $0 in sales, the net buying activity of $106.6M signals strong executive confidence. Partners 16, L.p. Nea (Executive) leads the buying activity with $10.0M in transactions across all time.